PIM1 and prostate cancer: Conversely, by acting as a suppressor, PIM1 is frequently downregulated in other human malignancies, such as prostate cancer, pancreatic ductal carcinoma and non-small-cell lung cancer; in these cases, PIM1 expression is correlated with a good prognosis26–28.